Unknown

Dataset Information

0

?2-Adrenergic receptor modulates mitochondrial metabolism and disease progression in recurrent/metastatic HPV(+) HNSCC.


ABSTRACT: The incidence of human papillomavirus-associated head and neck squamous cell carcinoma (HPV[?+?] HNSCC) is rapidly increasing. Although clinical management of primary HPV(?+?) HNSCC is relatively successful, disease progression, including recurrence and metastasis, is often fatal. Moreover, patients with progressive disease face limited treatment options and significant treatment-associated morbidity. These clinical data highlight the need to identify targetable mechanisms that drive disease progression in HPV(?+?) HNSCC to prevent and/or treat progressive disease. Interestingly, ?-adrenergic signaling has recently been associated with pro-tumor processes in several disease types. Here we show that an aggressive murine model of recurrent/metastatic HPV(?+?) HNSCC upregulates ?2-adrenergic receptor (?2AR) expression, concordant with significantly heightened mitochondrial metabolism, as compared with the parental model from which it spontaneously derived. ?-Adrenergic blockade effectively inhibits in vitro proliferation and migratory capacity in this model, effects associated with an attenuation of hyperactive mitochondrial respiration. Importantly, propranolol, a clinically available nonselective ?-blocker, significantly slows primary tumor growth, inhibits metastatic development, and shows additive benefit alongside standard-of-care modalities in vivo. Further, via CRISPR/Cas9 technology, we show that the hyperactive mitochondrial metabolic profile and aggressive in vivo phenotype of this recurrent/metastatic model are dependent on ?2AR expression. These data implicate ?2AR as a modulator of mitochondrial metabolism and disease progression in HPV(?+?) HNSCC, and warrant further investigation into the use of ?-blockers as low cost, relatively tolerable, complementary treatment options in the clinical management of this disease.

SUBMITTER: Lucido CT 

PROVIDER: S-EPMC6175933 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

β<sub>2</sub>-Adrenergic receptor modulates mitochondrial metabolism and disease progression in recurrent/metastatic HPV(+) HNSCC.

Lucido Christopher T CT   Callejas-Valera Juan L JL   Colbert Paul L PL   Vermeer Daniel W DW   Miskimins W Keith WK   Spanos William C WC   Vermeer Paola D PD  

Oncogenesis 20181008 10


The incidence of human papillomavirus-associated head and neck squamous cell carcinoma (HPV[ + ] HNSCC) is rapidly increasing. Although clinical management of primary HPV( + ) HNSCC is relatively successful, disease progression, including recurrence and metastasis, is often fatal. Moreover, patients with progressive disease face limited treatment options and significant treatment-associated morbidity. These clinical data highlight the need to identify targetable mechanisms that drive disease pro  ...[more]

Similar Datasets

| S-EPMC7432755 | biostudies-literature
| S-EPMC5029697 | biostudies-literature
| S-EPMC3782431 | biostudies-literature
2012-11-30 | GSE38271 | GEO
2012-11-30 | E-GEOD-38271 | biostudies-arrayexpress
| S-EPMC7668037 | biostudies-literature
| S-EPMC5322260 | biostudies-literature
2012-11-01 | GSE38263 | GEO
2012-11-01 | E-GEOD-38263 | biostudies-arrayexpress
| S-EPMC10045647 | biostudies-literature